WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
WX was delisted on the 10th of December, 2015.
165 hedge funds and large institutions have $2.03B invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2014 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 51 increasing their positions, 65 reducing their positions, and 16 closing their positions.
183% more call options, than puts
Call options by funds: $895K | Put options by funds: $316K
63% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 16
5% more funds holding
Funds holding: 157 → 165 (+8)
2% more capital invested
Capital invested by funds: $2B → $2.03B (+$32.8M)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
22% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 65
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$41.5M |
| 2 |
MICM
Matthews International Capital Management
San Francisco,
California
|
+$35.9M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
+$23M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$17.5M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$12.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCIM
Black Creek Investment Management
Toronto,
Ontario, Canada
|
-$30.4M |
| 2 |
William Blair & Company
Chicago,
Illinois
|
-$22.8M |
| 3 |
Principal Financial Group
Des Moines,
Iowa
|
-$15.9M |
| 4 |
CCM
Century Capital Management
Boston,
Massachusetts
|
-$12.9M |
| 5 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$9.77M |
WX Hedge Fund Activity: Q4 2014 in Review
165 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q4 2014, worth a combined $2.03B — up 1.6% from $2B a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new WX positions and 16 closed out — a net gain of 10 holders — while 51 added to existing stakes and 65 trimmed.
The largest buyer was Fidelity International, adding an estimated $41.5M. The largest seller was Black Creek Investment Management, exiting entirely with an estimated $30.4M sold.
- 165 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q4 2014, up from 157 in Q3 2014.
- Funds reported $2.03B of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q4 2014, up 1.6% quarter-over-quarter.
- 26 funds opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q4 2014 and 16 closed out, a net change of +10 holders.
- The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS buyer in Q4 2014 was Fidelity International, an estimated $41.5M added.
- The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS seller in Q4 2014 was Black Creek Investment Management, an estimated $30.4M sold.
Based on aggregated 13F filings for Q4 2014.